Greenland Mines Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Greenland Mines Ltd
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
/ 
Others were interested in
Frequently asked questions
To buy Greenland Mines Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Greenland Mines Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Greenland Mines Ltd is GRML:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Greenland Mines Ltd has its primary listing on NASDAQ. You can trade Greenland Mines Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Greenland Mines Ltd is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Greenland Mines Ltd as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Greenland Mines Ltd or others.